Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

The evolutionary landscape of antifolate resistance in Plasmodium falciparum.

Costanzo MS, Hartl DL.

J Genet. 2011 Aug;90(2):187-90. Review.

2.

Selection of drug resistant mutants from random library of Plasmodium falciparum dihydrofolate reductase in Plasmodium berghei model.

Tipsuwan W, Srichairatanakool S, Kamchonwongpaisan S, Yuthavong Y, Uthaipibull C.

Malar J. 2011 May 10;10:119. doi: 10.1186/1475-2875-10-119.

3.
4.

Tracing the origins and signatures of selection of antifolate resistance in island populations of Plasmodium falciparum.

Salgueiro P, Vicente JL, Ferreira C, Teófilo V, Galvão A, do Rosário VE, Cravo P, Pinto J.

BMC Infect Dis. 2010 Jun 9;10:163. doi: 10.1186/1471-2334-10-163.

5.

Fitness trade-offs in the evolution of dihydrofolate reductase and drug resistance in Plasmodium falciparum.

Costanzo MS, Brown KM, Hartl DL.

PLoS One. 2011;6(5):e19636. doi: 10.1371/journal.pone.0019636. Epub 2011 May 23.

7.

Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia.

Mkulama MA, Chishimba S, Sikalima J, Rouse P, Thuma PE, Mharakurwa S.

Malar J. 2008 May 21;7:87. doi: 10.1186/1475-2875-7-87.

8.

Molecular modeling of wild-type and antifolate resistant mutant Plasmodium falciparum DHFR.

Delfino RT, Santos-Filho OA, Figueroa-Villar JD.

Biophys Chem. 2002 Aug 2;98(3):287-300.

PMID:
12128181
9.

Similar trends of pyrimethamine resistance-associated mutations in Plasmodium vivax and P. falciparum.

Alam MT, Bora H, Bharti PK, Saifi MA, Das MK, Dev V, Kumar A, Singh N, Dash AP, Das B, Wajihullah, Sharma YD.

Antimicrob Agents Chemother. 2007 Mar;51(3):857-63. Epub 2006 Dec 28.

10.

The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations.

Heinberg A, Kirkman L.

Ann N Y Acad Sci. 2015 Apr;1342:10-8. doi: 10.1111/nyas.12662. Epub 2015 Feb 18. Review.

PMID:
25694157
11.
12.

Drug resistance and genetic diversity of Plasmodium falciparum parasites from suriname.

Peek R, VAN Gool T, Panchoe D, Greve S, Bus E, Resida L.

Am J Trop Med Hyg. 2005 Nov;73(5):833-8.

13.

Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins.

Wang P, Lee CS, Bayoumi R, Djimde A, Doumbo O, Swedberg G, Dao LD, Mshinda H, Tanner M, Watkins WM, Sims PF, Hyde JE.

Mol Biochem Parasitol. 1997 Nov;89(2):161-77.

PMID:
9364963
14.
15.

Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase.

Sirawaraporn W, Sathitkul T, Sirawaraporn R, Yuthavong Y, Santi DV.

Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1124-9.

16.

Short communication: Prevalence of mutations associated with resistance to atovaquone and to the antifolate effect of proguanil in Plasmodium falciparum isolates from northern Ghana.

Muehlen M, Schreiber J, Ehrhardt S, Otchwemah R, Jelinek T, Bienzle U, Mockenhaupt FP.

Trop Med Int Health. 2004 Mar;9(3):361-3.

PMID:
14996365
17.

Molecular surveillance of drug resistance through imported isolates of Plasmodium falciparum in Europe.

Jelinek T, Peyerl-Hoffmann G, Mühlberger N, Wichmann O, Wilhelm M, Schmider N, Grobusch MP, von Sonnenburg F, Gascon J, Laferl H, Hatz C, Alifrangis M, Burchard G, McWhinney P, Schulze M, Kollaritsch H, da Cunha S, Beran J, Kern P, Gjørup I, Cuadros J.

Malar J. 2002 Oct 11;1:11. Epub 2002 Oct 11.

18.

Basis for antifolate action and resistance in malaria.

Yuthavong Y.

Microbes Infect. 2002 Feb;4(2):175-82.

PMID:
11880049
19.

Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite.

Mita T, Ohashi J, Venkatesan M, Marma AS, Nakamura M, Plowe CV, Tanabe K.

J Infect Dis. 2014 Jan 1;209(1):130-9. doi: 10.1093/infdis/jit415. Epub 2013 Aug 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk